{"url_path":"/sec/axsm/8-k/2026-06-03/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1579428/0001193125-26-254708-index.html","accession_number":"0001193125-26-254708","cik":"0001579428","ticker":"AXSM","issuer_name":"Axsome Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1579428/0001193125-26-254708-index.html","primary_entity_key":"0001579428","primary_entity_name":"Axsome Therapeutics, Inc."},"word_count":83,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\n \n\n \n\nExhibit No.\n\nDescription\n\n99.1\n\n \n\n[Press Release dated June 3, 2026.](axsm-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nAxsome Therapeutics, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 3, 2026\n\nBy:\n\n/s/ Herriot Tabuteau, M.D.\n\n \n\n \n\nName:\n\nTitle:\n\nHerriot Tabuteau, M.D.\nPresident and Chief Executive Officer"}